EUVIMEDEUVIMED entdecken
Crossref

Risk factors in ICU patients with initial acquisition of carbapenemase-resistant Klebsiella Pneumoniae

L Wu, J Ying, Z Jiang, L Zhang, Y Cai, C Zhou, Y Xu, S Lei

The International Journal of Tuberculosis and Lung Disease · 2023

DOI: 10.5588/ijtld.23.0043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, 2023. Verfasst von L Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Respiratory and Critical Care Medicine, and. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Klebsiella Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To identify the risk factors associated with antimicrobial use on the initial acquisition of carbapenem-resistant Klebsiella pneumoniae (CRKP) in elderly intensive care unit (ICU) patients. METHODS: Respiratory secretion, blood, urine, anal swab and peritoneal drainage samples from all elderly patients with non-colonised CRKP who had been hospitalised from January 2021 to December 2022 were collected, and screened for CRKP colonisation using surveillance culture at the time of the first ICU admission and weekly thereafter in Zhejiang Provincial Hospital of Chinese Medicine, Zhejiang, China. Cumulative antibiotic variables included duration of antibiotic use, total amount of antimicrobials received in grams, total antibiotic consumption (defined daily dose) and the types of antimicrobial exposure. A time-dependent model based on Cox regression analysis was used to investigate the effect of each variable on the initial acquisition of CRKP infection or colonisation. RESULTS: Of 214 patients, 44 were infected or had CRKP colonies and death rate was 34.1%. males were the risk factor for acquiring CRKP in culture (HR 2.12, 95% CI 1.06–4.21; P = 0.033). It is notable that the hazard of acquiring CRKP increased by 9% with every single-point increase in the APACHE II score (HR 1.09, 95% CI 1.01–1.18; P = 0.025). The hazard of acquiring CRKP doubled when carbapenems were administered (HR 1.81, 95% CI 1.42–2.30; P < 0.001), In contrast, exposure to quinolone antimicrobials had a smaller effect on acquiring CRKP (HR 1.07; 95% CI 1.01–1.14; P = 0.024). CONCLUSION: This study found that male sex, APACHE II score and exposure to quinolones and carbapenems were independent risk factors for acquiring CRKP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klebsiella pneumoniaeKlebsiella InfectionsHumansMaleAgedDrug Resistance, BacterialAnti-Bacterial AgentsCarbapenemsRisk FactorsIntensive Care UnitsBacterial Proteinsbeta-Lactamases

Substanzen

Anti-Bacterial AgentsCarbapenemscarbapenemaseBacterial Proteinsbeta-Lactamases

Autor:innen und Institutionen

  • Departments of Respiratory and Critical Care Medicine, and.
  • Departments of Obstetrics and Gynecology, The Affiliated Cangnan Hospital of Wenzhou Medical University, Cangnan, Zhejiang.
  • Department of Emergency Medicine, The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, Zhejiang.
  • Department of Cardiology, Hangzhou Ninth People's Hospital, Hangzhou, Zhejiang.
  • Intensive Care Unit, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.

Zitieren

APA

Wu, L., Ying, J., Jiang, Z., Zhang, L., Cai, Y., Zhou, C., Xu, Y., & Lei, S. (2023). Risk factors in ICU patients with initial acquisition of carbapenemase-resistant Klebsiella Pneumoniae. The International Journal of Tuberculosis and Lung Disease. https://doi.org/10.5588/ijtld.23.0043

Vancouver

Wu L, Ying J, Jiang Z, Zhang L, Cai Y, Zhou C, et al. Risk factors in ICU patients with initial acquisition of carbapenemase-resistant Klebsiella Pneumoniae. The International Journal of Tuberculosis and Lung Disease. 2023. doi:10.5588/ijtld.23.0043

BibTeX
@article{Wu2023,
  author = {Wu, L and Ying, J and Jiang, Z and Zhang, L and Cai, Y and Zhou, C and Xu, Y and Lei, S},
  title = {Risk factors in ICU patients with initial acquisition of carbapenemase-resistant Klebsiella Pneumoniae},
  journal = {The International Journal of Tuberculosis and Lung Disease},
  year = {2023},
  doi = {10.5588/ijtld.23.0043}
}
Kostenlos starten →